HUK-COBURG vs Oscar

HUK-Coburg Retains OMD as Media Agency After Competitive Review

German insurance group HUK-Coburg has concluded its highly anticipated media review, deciding to retain its long-term incumbent agency, OMD Munich. OMD has managed the account since first winning it in 2014. The decision secures an estimated €50 million media budget for Omnicom Media Group, which saw HUK-Coburg spend approximately €52 million gross in 2025 (with €37 million dedicated to linear TV). This retention represents a key stabilizing win for Omnicom during a period of massive structural changes. Following Omnicom's global acquisition of IPG, the group is undergoing a major reorganization in Germany, which includes the creation of the new agency Hearts United and several high-profile C-level executive moves under newly appointed OMD CEO Jan Wilczewski.

• HUK-Coburg has retained OMD Munich as its media agency of record following a competitive pitch.
• OMD has held the advertising mandate for the insurer since 2014.
• HUK-Coburg's gross media budget was €52 million in 2025, with €37 million spent on linear TV advertising.

The making of a brand: Oscar Health redesigns its family of brands around individual choice

CMO Kristen Prestano explains how Oscar Health’s new business model connects insurance, healthcare shopping and technology through one consumer promise.

10-Q Financial Filing Analysis for Oscar (2026-08-07)

Oscar Health, Inc. reported substantial revenue growth and a return to profitability for the second quarter of 2026 ended June 30, 2026. Total revenue reached $4.88 billion for Q2 2026, up 70.4% from $2.86 billion in Q2 2025, driven by strong membership growth to approximately 3.0 million effectuated members (a 46% year-over-year increase) and disciplined rate increases. Operating performance improved significantly, posting operating income of $388.6 million and net income attributable to Oscar Health of $361.8 million, compared to an operating loss of $230.5 million and a net loss of $228.4 million in the prior-year period. The Medical Loss Ratio (MLR) improved markedly to 79.2% from 91.1% in Q2 2025, supported by disciplined pricing and favorable prior-period reserve developments. The company also maintained strong liquidity, with $4.08 billion in cash and cash equivalents, expanded short-term investments, and an undrawn $475.0 million revolving credit facility.

• Q2 2026 total revenue increased 70.4% YoY to $4.88 billion, with net income attributable to Oscar reaching $361.8 million ($1.10 diluted EPS).
• Medical Loss Ratio (MLR) improved 1,190 basis points YoY to 79.2% for Q2 2026, while the SG&A expense ratio declined to 14.2% from 18.7%.
• Total effectuated membership expanded 46% YoY to 2,963,002 members as of June 30, 2026.

Oscar Health is building the new consumer health economy

At Investor Day, Oscar Health raised its 2026 earnings outlook and outlined how its ACA leadership, CHOICE adoption, Lucie and AI advantage will support durable, profitable growth.